{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:30:00Z","timestamp":1759411800485,"version":"3.37.3"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP52155"],"award-info":[{"award-number":["OPP52155"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Antigen polymorphisms in essential malarial antigens are a key challenge to the design and development of broadly effective malaria vaccines. The effect of polymorphisms on antibody responses is fairly well studied while much fewer studies have assessed this for T cell responses. This study investigated the effect of allelic polymorphisms in the malarial antigen apical membrane antigen 1 (AMA1) on<jats:italic>ex vivo<\/jats:italic>T cell-specific IFN-\u03b3 responses in subjects with lifelong exposure to malaria. Human leukocyte antigen (HLA) class I-restricted peptides from the 3D7 clone AMA1 were bioinformatically predicted and those with variant amino acid positions used to select corresponding allelic sequences from the 7G8, FVO, FC27 and tm284 parasite strains. A total of 91 AMA1 9-10mer peptides from the five parasite strains were identified, synthesized, grouped into 42 allele sets and used to stimulate PBMCs from seven HLA class 1-typed subjects in IFN-\u03b3 ELISpot assays. PBMCs from four of the seven subjects (57%) made positive responses to 18 peptides within 12 allele sets. Fifty percent of the 18 positive peptides were from the 3D7 parasite variant. Amino acid substitutions that were associated with IFN-\u03b3 response abrogation were more frequently found at positions 1 and 6 of the tested peptides, but substitutions did not show a clear pattern of association with response abrogation. Thus, while we show some evidence of polymorphisms affecting T cell response induction, other factors including TCR recognition of HLA-peptide complexes may also be at play.<\/jats:p>","DOI":"10.1371\/journal.pone.0257219","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T17:35:28Z","timestamp":1631295328000},"page":"e0257219","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative analysis of the ex vivo IFN-gamma responses to CD8+ T cell epitopes within allelic forms of PfAMA1 in subjects with natural exposure to malaria"],"prefix":"10.1371","volume":"16","author":[{"given":"Omarine N.","family":"Nlinwe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebenezer A.","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwadwo","family":"Akyea-Mensah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Kyei-Baafour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harini","family":"Ganeshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Belmonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjoern","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Villasante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Sedegah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5483-9985","authenticated-orcid":true,"given":"Kwadwo Asamoah","family":"Kusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"key":"pone.0257219.ref001","unstructured":"World malaria report 2020. https:\/\/www.who.int\/publications-detail-redirect\/9789240015791. Accessed 26 Jun 2021."},{"key":"pone.0257219.ref002","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030. WHO Press; 2015."},{"key":"pone.0257219.ref003","unstructured":"Anonymous. First malaria vaccine receives positive scientific opinion from EMA. European Medicines Agency. 2018. https:\/\/www.ema.europa.eu\/en\/news\/first-malaria-vaccine-receives-positive-scientific-opinion-ema. Accessed 15 Mar 2021."},{"key":"pone.0257219.ref004","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial","volume":"15","author":"MT White","year":"2015","journal-title":"The Lancet Infectious Diseases"},{"key":"pone.0257219.ref005","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-Year Efficacy of RTS,S\/AS01 Malaria Vaccine among Young African Children","volume":"374","author":"A Olotu","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0257219.ref006","doi-asserted-by":"crossref","first-page":"e61395","DOI":"10.1371\/journal.pone.0061395","article-title":"The relationship between RTS,S vaccine-induced antibodies, CD4(+) T cell responses and protection against Plasmodium falciparum infection","volume":"8","author":"MT White","year":"2013","journal-title":"PLoSONE"},{"key":"pone.0257219.ref007","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic Diversity and Protective Efficacy of the RTS,S\/AS01 Malaria Vaccine","volume":"373","author":"DE Neafsey","year":"2015","journal-title":"NEnglJMed"},{"key":"pone.0257219.ref008","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/infdis\/jis709","article-title":"Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications","volume":"207","author":"A Ouattara","year":"2013","journal-title":"JInfectDis"},{"key":"pone.0257219.ref009","doi-asserted-by":"crossref","first-page":"e38898","DOI":"10.1371\/journal.pone.0038898","article-title":"Humoral immune responses to a single allele PfAMA1 vaccine in healthy malaria-naive adults","volume":"7","author":"EJ Remarque","year":"2012","journal-title":"PLoSONE"},{"key":"pone.0257219.ref010","first-page":"e89154","article-title":"Protection against Plasmodium falciparum malaria by PfSPZ Vaccine","volume":"2","author":"JE Epstein","year":"2017","journal-title":"JCIInsight"},{"key":"pone.0257219.ref011","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1371\/journal.pmed.0040093","article-title":"Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali","volume":"4","author":"SL Takala","year":"2007","journal-title":"PLoS Med"},{"key":"pone.0257219.ref012","doi-asserted-by":"crossref","first-page":"e8110","DOI":"10.1371\/journal.pone.0008110","article-title":"Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity","volume":"4","author":"KA Kusi","year":"2009","journal-title":"PLoS ONE"},{"key":"pone.0257219.ref013","first-page":"422","article-title":"Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1","volume":"73","author":"A Cortes","year":"2005","journal-title":"InfectImmun"},{"key":"pone.0257219.ref014","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2012-06-437202","article-title":"Peptide length determines the outcome of TCR\/peptide-MHCI engagement","volume":"121","author":"J Ekeruche-Makinde","year":"2013","journal-title":"Blood"},{"key":"pone.0257219.ref015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2567.2011.03542.x","article-title":"Steric recognition of T-cell receptor contact residues is required to map mutant epitopes by immunoinformatical programmes","volume":"136","author":"S-C Hsu","year":"2012","journal-title":"Immunology"},{"key":"pone.0257219.ref016","doi-asserted-by":"crossref","first-page":"e0163026","DOI":"10.1371\/journal.pone.0163026","article-title":"Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes","volume":"11","author":"M Sedegah","year":"2016","journal-title":"PLoSONE"},{"key":"pone.0257219.ref017","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2567.1998.00514.x","article-title":"Human and murine T-cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy","volume":"94","author":"Y Zevering","year":"1998","journal-title":"Immunology"},{"key":"pone.0257219.ref018","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.4049\/jimmunol.142.11.4000","article-title":"Human T cell recognition of polymorphic epitopes from malaria circumsporozoite protein","volume":"142","author":"AS De Groot","year":"1989","journal-title":"JImmunol"},{"key":"pone.0257219.ref019","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/j.1460-2075.1988.tb03104.x","article-title":"Human T cells recognize polymorphic and non-polymorphic regions of the Plasmodium falciparum circumsporozoite protein","volume":"7","author":"M Guttinger","year":"1988","journal-title":"EMBO J"},{"key":"pone.0257219.ref020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073117","article-title":"Nef-Specific CD8+ T Cell Responses Contribute to HIV-1 Immune Control","volume":"8","author":"E Adland","year":"2013","journal-title":"PLoS One"},{"key":"pone.0257219.ref021","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/346629a0","article-title":"Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo","volume":"346","author":"H Pircher","year":"1990","journal-title":"Nature"},{"key":"pone.0257219.ref022","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.vaccine.2018.03.023","article-title":"T-cell responses against Malaria: Effect of parasite antigen diversity and relevance for vaccine development","volume":"36","author":"ON Nlinwe","year":"2018","journal-title":"Vaccine"},{"key":"pone.0257219.ref023","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12936-016-1098-8","article-title":"Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria","volume":"15","author":"H Ganeshan","year":"2016","journal-title":"MalarJ"},{"key":"pone.0257219.ref024","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13073-016-0288-x","article-title":"NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets","volume":"8","author":"M Nielsen","year":"2016","journal-title":"Genome Med"},{"key":"pone.0257219.ref025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/psc.2836","article-title":"Advances in Fmoc solid-phase peptide synthesis","volume":"22","author":"R Behrendt","year":"2016","journal-title":"Journal of Peptide Science"},{"key":"pone.0257219.ref026","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12916-017-0923-4","article-title":"Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial","volume":"15","author":"J Walk","year":"2017","journal-title":"BMC Medicine"},{"key":"pone.0257219.ref027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36493-y","article-title":"Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans","volume":"9","author":"P Sondo","year":"2019","journal-title":"Sci Rep"},{"key":"pone.0257219.ref028","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.meegid.2018.08.018","article-title":"Intra-host dynamics of co-infecting parasite genotypes in asymptomatic malaria patients","volume":"65","author":"SC Nkhoma","year":"2018","journal-title":"Infection, Genetics and Evolution"},{"key":"pone.0257219.ref029","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12879-018-3350-z","article-title":"Seasonal variations in Plasmodium falciparum genetic diversity and multiplicity of infection in asymptomatic children living in southern Ghana","volume":"18","author":"J Adjah","year":"2018","journal-title":"BMC Infect Dis"},{"key":"pone.0257219.ref030","doi-asserted-by":"crossref","first-page":"e0228177","DOI":"10.1371\/journal.pone.0228177","article-title":"Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population","volume":"15","author":"KA Kusi","year":"2020","journal-title":"PLOS ONE"},{"key":"pone.0257219.ref031","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1475-2875-12-185","article-title":"Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)","volume":"12","author":"M Sedegah","year":"2013","journal-title":"MalarJ"},{"key":"pone.0257219.ref032","doi-asserted-by":"crossref","first-page":"e24586","DOI":"10.1371\/journal.pone.0024586","article-title":"Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults","volume":"6","author":"M Sedegah","year":"2011","journal-title":"PLoS ONE"},{"key":"pone.0257219.ref033","doi-asserted-by":"crossref","first-page":"e106241","DOI":"10.1371\/journal.pone.0106241","article-title":"Sterile immunity to malaria after DNA prime\/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes","volume":"9","author":"M Sedegah","year":"2014","journal-title":"PLoS ONE"},{"key":"pone.0257219.ref034","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00251-011-0552-6","article-title":"HLA class I allele promiscuity revisited","volume":"63","author":"X Rao","year":"2011","journal-title":"Immunogenetics"},{"key":"pone.0257219.ref035","first-page":"2419","article-title":"Extensive HLA class I allele promiscuity among viral CTL epitopes","volume":"37","author":"N Frahm","year":"2007","journal-title":"EurJImmunol"},{"key":"pone.0257219.ref036","doi-asserted-by":"crossref","first-page":"42768","DOI":"10.1038\/srep42768","article-title":"Identification of the core regulators of the HLA I-peptide binding process","volume":"7","author":"Y-H Zhang","year":"2017","journal-title":"Scientific Reports"},{"key":"pone.0257219.ref037","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00251-019-01134-9","article-title":"Revealing factors determining immunodominant responses against dominant epitopes","volume":"72","author":"W Ritmahan","year":"2020","journal-title":"Immunogenetics"},{"key":"pone.0257219.ref038","first-page":"187","article-title":"Cytotoxic T lymphocytes in humans exposed to Plasmodium falciparum by immunization or natural exposure","volume":"189","author":"SL Hoffman","year":"1994","journal-title":"CurrTopMicrobiolImmunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:01:12Z","timestamp":1673222472000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257219"}},"subtitle":[],"editor":[{"given":"Luzia Helena","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0257219","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2021,9,10]]}}}